Influenza vaccination in pregnant women: a systematic review.

ISRN Preventive Medicine Pub Date : 2013-11-07 eCollection Date: 2013-01-01 DOI:10.5402/2013/879493
Tais F Galvao, Marcus T Silva, Ivan R Zimmermann, Luiz Antonio B Lopes, Eneida F Bernardo, Mauricio G Pereira
{"title":"Influenza vaccination in pregnant women: a systematic review.","authors":"Tais F Galvao,&nbsp;Marcus T Silva,&nbsp;Ivan R Zimmermann,&nbsp;Luiz Antonio B Lopes,&nbsp;Eneida F Bernardo,&nbsp;Mauricio G Pereira","doi":"10.5402/2013/879493","DOIUrl":null,"url":null,"abstract":"<p><p>Objective. To assess the effects of the inactivated influenza virus vaccine on influenza outcomes in pregnant women and their infants. Methods. We performed a systematic review of the literature. We searched for randomized controlled trials and cohort studies in the MEDLINE, Embase, and other relevant databases (inception to September 2013). Two researchers selected studies and extracted the data independently. We used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the quality of the evidence. Results. We included eight studies out of 1,967 retrieved records. Influenza vaccination in pregnant women significantly reduced the incidence of influenza-like illness in mothers and their infants when compared with control groups (high-quality evidence) and reduced the incidence of laboratory-confirmed influenza in infants (moderate-quality evidence). No difference was found with regard to influenza-like illness with fever higher than 38°C (moderate-quality evidence) or upper respiratory infection (very-low-quality evidence) in mothers and infants. Conclusions. Maternal vaccination against influenza was shown to prevent influenza-like illness in women and infants; no differences were found for other outcomes. As the quality of evidence was not high overall, further research is needed to increase confidence and could possibly change these estimates. </p>","PeriodicalId":14536,"journal":{"name":"ISRN Preventive Medicine","volume":"2013 ","pages":"879493"},"PeriodicalIF":0.0000,"publicationDate":"2013-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2013/879493","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN Preventive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2013/879493","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

Abstract

Objective. To assess the effects of the inactivated influenza virus vaccine on influenza outcomes in pregnant women and their infants. Methods. We performed a systematic review of the literature. We searched for randomized controlled trials and cohort studies in the MEDLINE, Embase, and other relevant databases (inception to September 2013). Two researchers selected studies and extracted the data independently. We used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the quality of the evidence. Results. We included eight studies out of 1,967 retrieved records. Influenza vaccination in pregnant women significantly reduced the incidence of influenza-like illness in mothers and their infants when compared with control groups (high-quality evidence) and reduced the incidence of laboratory-confirmed influenza in infants (moderate-quality evidence). No difference was found with regard to influenza-like illness with fever higher than 38°C (moderate-quality evidence) or upper respiratory infection (very-low-quality evidence) in mothers and infants. Conclusions. Maternal vaccination against influenza was shown to prevent influenza-like illness in women and infants; no differences were found for other outcomes. As the quality of evidence was not high overall, further research is needed to increase confidence and could possibly change these estimates.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
孕妇接种流感疫苗:系统综述。
目标。评估灭活流感病毒疫苗对孕妇及其婴儿流感结局的影响。方法。我们对文献进行了系统的回顾。我们在MEDLINE、Embase和其他相关数据库(创建至2013年9月)中检索了随机对照试验和队列研究。两位研究者独立选择研究并提取数据。我们使用分级推荐评估、发展和评价(GRADE)方法来评估证据的质量。结果。我们从1967份检索到的记录中纳入了8项研究。与对照组相比,孕妇接种流感疫苗显著降低了母亲及其婴儿流感样疾病的发病率(高质量证据),并降低了婴儿实验室确诊流感的发病率(中等质量证据)。在母亲和婴儿发烧高于38°C(中等质量证据)或上呼吸道感染(极低质量证据)的流感样疾病方面没有发现差异。结论。孕妇接种流感疫苗已被证明可预防妇女和婴儿的流感样疾病;其他结果没有发现差异。由于证据的质量总体上不高,需要进一步的研究来增加信心,并可能改变这些估计。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Prevalence and Risk Factors of Hypertension among Male Occupational Bus Drivers in North Kerala, South India: A Cross-Sectional Study. Utilization of maternal and child health care services by primigravida females in urban and rural areas of India. Knowledge, Attitude, and Practice of Hand Hygiene among Medical and Nursing Students at a Tertiary Health Care Centre in Raichur, India. Cervical cancer: community perception and preventive practices in an urban neighborhood of lagos (Nigeria). Prevalence of Cardiovascular Risk Factors among Tile and Ceramic Workers in Yazd, Iran.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1